Does Quinolone- or Macrolide-Resistant Streptococcus agalactiae Bacteremia Affect Patient Outcome? A Multicenter Cohort Study.
Adolescent
Adult
Aged
Aged, 80 and over
Bacteremia
/ drug therapy
Cause of Death
Child
Cohort Studies
Drug Resistance, Multiple, Bacterial
/ drug effects
Female
Humans
Japan
/ epidemiology
Macrolides
/ pharmacology
Male
Microbial Sensitivity Tests
Middle Aged
Mortality
Quinolines
/ pharmacology
Streptococcal Infections
/ drug therapy
Streptococcus agalactiae
/ drug effects
Treatment Outcome
Young Adult
Streptococcus agalactiae
macrolide
quinolone
resistance
Journal
Japanese journal of infectious diseases
ISSN: 1884-2836
Titre abrégé: Jpn J Infect Dis
Pays: Japan
ID NLM: 100893704
Informations de publication
Date de publication:
24 May 2021
24 May 2021
Historique:
pubmed:
3
11
2020
medline:
24
8
2021
entrez:
2
11
2020
Statut:
ppublish
Résumé
The prevalence of quinolone- and macrolide-resistant Group B Streptococcus (GBS) is increasing worldwide, but the relationship between the resistance of GBS to these antibiotics and patient outcome remains unclear. Therefore, we evaluated whether blood stream infection caused by quinolone- or macrolide-resistant GBS is associated with high mortality. Our findings in 77 patients with GBS bacteremia demonstrate that quinolone and macrolide resistance may not be risk factors for 30-day mortality.
Identifiants
pubmed: 33132300
doi: 10.7883/yoken.JJID.2020.589
doi:
Substances chimiques
Macrolides
0
Quinolines
0
quinoline
E66400VT9R
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM